Russian scientists have created a new anti-virus drug that they allege can help neutralize the potentially deadly H5N1 bird flu virus.
The Russian news agency ITAR-Tass reported scientists from the Russian Academy of Medical Sciences and the Russian Academy of Sciences developed the new drug that is far superior to current treatments.
Called Triazoverin, the academy's newest creation must wait for official state approval.
Russian Academy of Medical Sciences official Oleg Kiselev said the drug represents "a major achievement of Russian science and a result of fruitful cooperation of the two leading institutes of the Russian Academy of Sciences and the Russian Academy of Medical Sciences."
He added the new drug is unique in its ability to act at any stage of an infection, no matter how severe.
ITAR-Tass said the development project won funding from the Science of the Russian Federation and the Russian Ministry of Education.
Copyright 2007 by United Press International
Explore further: Ionic and covalent drug delivery